• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撒哈拉以南非洲地区鲍曼不动杆菌和铜绿假单胞菌碳青霉烯类耐药率的系统评价和荟萃分析。

Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis.

机构信息

Department of Microbiology, University of Lagos, Akoka, Lagos, Nigeria.

School of Life Sciences, University of Warwick, Coventry, United Kingdom.

出版信息

PLoS One. 2023 Nov 28;18(11):e0287762. doi: 10.1371/journal.pone.0287762. eCollection 2023.

DOI:10.1371/journal.pone.0287762
PMID:38015906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10684001/
Abstract

Carbapenems are effective drugs against bacterial pathogens and resistance to them is considered a great public health threat, especially in notorious nosocomial pathogens like Acinetobacter baumannii and Pseudomonas aeruginosa. In this study, we aimed to determine the prevalence of carbapenem resistance in A. baumannii and P. aeruginosa infections in Sub-Saharan Africa. Databases (PubMed, Scopus, Web of Science, and African Journal Online) were systematically searched following the Preferred Reporting Items for Systematic review and meta-analysis protocols (PRISMA-P) 2020 statements for articles reporting carbapenem-resistant Acinetobacter baumannii (CRAB) and carbapenem-resistant Pseudomonas aeruginosa (CRPA) prevalence between 2012 and 2022. Pooled prevalence was determined with the random effect model and funnel plots were used to determine heterogeneity in R. A total of 47 articles were scanned for eligibility, among which 25 (14 for carbapenem-resistant A. baumannii and 11 for carbapenem-resistant P. aeruginosa) were included in the study after fulfilling the eligibility criteria. The pooled prevalence of CRPA in the present study was estimated at 8% (95% CI; 0.02-0.17; I2 = 98%; P <0.01). There was high heterogeneity (Q = 591.71, I2 = 98.9%; P<0.0001). In addition, this study's pooled prevalence of CRAB was estimated at 20% (95% CI; 0.04-0.43; I2 = 99%; P <0.01). There was high heterogeneity (Q = 1452.57, I2 = 99%; P<0.0001). Also, a funnel plot analysis of the studies showed high degree of heterogeneity. The carbapenemase genes commonly isolated from A. baumannii in this study include blaOXA23, blaOXA48, blaGES., blaNDM, blaVIM, blaOXA24, blaOXA58, blaOXA51, blaSIM-1, blaOXA40, blaOXA66, blaOXA69, blaOXA91, with blaOXA23 and blaVIM being the most common. On the other hand, blaNDM, blaVIM, blaIMP, blaOXA48, blaOXA51, blaSIM-1, blaOXA181, blaKPC, blaOXA23, blaOXA50 were the commonly isolated carbapenemase genes in P. aeruginosa, among which blaVIM and blaNDM genes were the most frequently isolated. Surveillance of drug-resistant pathogens in Sub-Saharan Africa is essential in reducing the region's disease burden. This study has shown that the region has significantly high multidrug-resistant pathogen prevalence. This is a wake-up call for policymakers to put in place measures to reduce the spread of these critical priority pathogens.

摘要

碳青霉烯类药物是对抗细菌病原体的有效药物,对它们的耐药性被认为是一个巨大的公共卫生威胁,尤其是在臭名昭著的医院病原体如鲍曼不动杆菌和铜绿假单胞菌中。在这项研究中,我们旨在确定撒哈拉以南非洲地区鲍曼不动杆菌和铜绿假单胞菌感染中碳青霉烯类药物耐药的流行率。根据系统评价和荟萃分析协议(PRISMA-P)2020 年的声明,我们对 2012 年至 2022 年间报告碳青霉烯类耐药鲍曼不动杆菌(CRAB)和碳青霉烯类耐药铜绿假单胞菌(CRPA)流行率的文章进行了数据库(PubMed、Scopus、Web of Science 和 African Journal Online)的系统搜索。使用随机效应模型确定汇总流行率,并使用漏斗图确定 R 中的异质性。总共扫描了 47 篇文章以确定其合格性,其中 25 篇(14 篇用于碳青霉烯类耐药鲍曼不动杆菌,11 篇用于碳青霉烯类耐药铜绿假单胞菌)在符合资格标准后被纳入研究。本研究中 CRPA 的汇总流行率估计为 8%(95%CI;0.02-0.17;I2 = 98%;P <0.01)。存在高度异质性(Q = 591.71,I2 = 98.9%;P<0.0001)。此外,本研究中 CRAB 的汇总流行率估计为 20%(95%CI;0.04-0.43;I2 = 99%;P <0.01)。存在高度异质性(Q = 1452.57,I2 = 99%;P<0.0001)。此外,研究的漏斗图分析显示出高度的异质性。本研究中从鲍曼不动杆菌中分离出的常见碳青霉烯酶基因包括 blaOXA23、blaOXA48、blaGES、blaNDM、blaVIM、blaOXA24、blaOXA58、blaOXA51、blaSIM-1、blaOXA40、blaOXA66、blaOXA69、blaOXA91,其中 blaOXA23 和 blaVIM 最为常见。另一方面,blaNDM、blaVIM、blaIMP、blaOXA48、blaOXA51、blaSIM-1、blaOXA181、blaKPC、blaOXA23、blaOXA50 是铜绿假单胞菌中常见的碳青霉烯酶基因,其中 blaVIM 和 blaNDM 基因最为常见。在撒哈拉以南非洲地区监测耐药病原体对于降低该地区的疾病负担至关重要。本研究表明,该地区具有显著较高的多药耐药病原体流行率。这是对政策制定者的一个警钟,需要采取措施减少这些关键优先病原体的传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/bcb22ae13182/pone.0287762.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/f4e4ae90877e/pone.0287762.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/914cb5b9ae29/pone.0287762.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/8f05d4e30b33/pone.0287762.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/11829c167ddd/pone.0287762.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/7b73425a00cb/pone.0287762.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/bcb22ae13182/pone.0287762.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/f4e4ae90877e/pone.0287762.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/914cb5b9ae29/pone.0287762.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/8f05d4e30b33/pone.0287762.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/11829c167ddd/pone.0287762.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/7b73425a00cb/pone.0287762.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7d/10684001/bcb22ae13182/pone.0287762.g006.jpg

相似文献

1
Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis.撒哈拉以南非洲地区鲍曼不动杆菌和铜绿假单胞菌碳青霉烯类耐药率的系统评价和荟萃分析。
PLoS One. 2023 Nov 28;18(11):e0287762. doi: 10.1371/journal.pone.0287762. eCollection 2023.
2
Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China.中国黑龙江省东部 ICU 爆发携带碳青霉烯酶 OXA-23 的耐碳青霉烯鲍曼不动杆菌。
BMC Infect Dis. 2019 May 22;19(1):452. doi: 10.1186/s12879-019-4073-5.
3
bla- and bla-mediated carbapenem resistance among Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the Mulago hospital intensive care unit in Kampala, Uganda.乌干达坎帕拉市穆拉戈医院重症监护病房分离的鲍曼不动杆菌和铜绿假单胞菌bla-和 bla 介导的碳青霉烯类耐药。
BMC Infect Dis. 2019 Oct 16;19(1):853. doi: 10.1186/s12879-019-4510-5.
4
Prevalence and Molecular Characterization of New Delhi Metallo-Beta-Lactamases in Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii from India.印度多重耐药铜绿假单胞菌和鲍曼不动杆菌中新型德里金属β-内酰胺酶的流行情况及分子特征
Microb Drug Resist. 2018 Jul/Aug;24(6):792-798. doi: 10.1089/mdr.2017.0078. Epub 2017 Oct 23.
5
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.分析 ICU 患者下呼吸道感染的鲍曼不动杆菌分离株的表型和分子特征。
Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15.
6
The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates.在塞尔维亚进行的首次全国性多中心鲍曼不动杆菌研究:出现了产 OXA-72、OXA-23 和 NDM-1 的分离株。
Antimicrob Resist Infect Control. 2020 Jul 6;9(1):101. doi: 10.1186/s13756-020-00769-8.
7
β-lactamase genes in carbapenem resistance Acinetobacter baumannii isolates from a Turkish university hospital.来自土耳其一家大学医院的耐碳青霉烯鲍曼不动杆菌分离株中的β-内酰胺酶基因
J Infect Dev Ctries. 2019 Jan 31;13(1):50-55. doi: 10.3855/jidc.10556.
8
Multidrug- and Extensively Drug-Resistant in a Tertiary Hospital from Brazil: The Importance of Carbapenemase Encoding Genes and Epidemic Clonal Complexes in a 10-Year Study.巴西一家三级医院的耐多药和广泛耐药 :10 年研究中碳青霉烯酶编码基因和流行克隆群的重要性。
Microb Drug Resist. 2019 Nov;25(9):1365-1373. doi: 10.1089/mdr.2019.0002. Epub 2019 Jul 30.
9
Extensively drug-resistant Acinetobacter baumannii co-producing VIM-2 and OXA-23 in intensive care units: Results of a one-day point prevalence in a Tunisian hospital.重症监护病房同时产 VIM-2 和 OXA-23 型金属β-内酰胺酶的广泛耐药鲍曼不动杆菌:突尼斯一家医院一日点患病率调查结果。
Infect Dis Now. 2022 Nov;52(8):426-431. doi: 10.1016/j.idnow.2022.09.003. Epub 2022 Sep 14.
10
Prevalence and Mechanisms of Carbapenem Resistance in : A Comprehensive Systematic Review of Cross-Sectional Studies from Iran.碳青霉烯类耐药在 :伊朗横断面研究的综合系统评价中的流行情况和机制。
Microb Drug Resist. 2020 Mar;26(3):270-283. doi: 10.1089/mdr.2018.0435. Epub 2019 May 24.

引用本文的文献

1
Global prevalence and antibiotic resistance profiles of carbapenem-resistant reported from 2014 to 2024: a systematic review and meta-analysis.2014年至2024年报道的耐碳青霉烯类细菌的全球流行率和抗生素耐药谱:一项系统评价和荟萃分析。
Front Microbiol. 2025 Jul 21;16:1599070. doi: 10.3389/fmicb.2025.1599070. eCollection 2025.
2
The global epidemiology of carbapenem-resistant .耐碳青霉烯类药物的全球流行病学情况
JAC Antimicrob Resist. 2025 Jul 29;7(4):dlaf134. doi: 10.1093/jacamr/dlaf134. eCollection 2025 Aug.
3
Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016-2019.

本文引用的文献

1
Antimicrobial susceptibility profiles of clinically important bacterial pathogens at the Kamuzu Central Hospital in Lilongwe, Malawi.马拉维利隆圭卡姆祖中央医院临床重要细菌病原体的药敏谱。
Malawi Med J. 2022 Mar;34(1):9-16. doi: 10.4314/mmj.v34i1.3.
2
Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study.碳青霉烯类耐药鲍曼不动杆菌和碳青霉烯类耐药铜绿假单胞菌的流行病学和结局:一项回顾性队列研究。
BMC Infect Dis. 2022 May 24;22(1):491. doi: 10.1186/s12879-022-07436-w.
3
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
非洲的抗菌药物耐药性:对2016年至2019年来自14个国家的数据进行的回顾性分析。
PLoS Med. 2025 Jun 24;22(6):e1004638. doi: 10.1371/journal.pmed.1004638. eCollection 2025 Jun.
4
Prevalence of ESBL-producing in sub-Saharan Africa: A meta-analysis using a One Health approach.撒哈拉以南非洲地区产超广谱β-内酰胺酶细菌的流行情况:一项采用“同一健康”方法的荟萃分析。
One Health. 2025 Jun 2;20:101090. doi: 10.1016/j.onehlt.2025.101090. eCollection 2025 Jun.
5
Prevalence and molecular epidemiology of carbapenem resistance in Asia: a systematic review and meta-analysis.亚洲碳青霉烯类耐药的流行情况及分子流行病学:一项系统评价和荟萃分析
Syst Rev. 2025 Jun 5;14(1):123. doi: 10.1186/s13643-025-02776-5.
6
Carbapenem-resistance in Acinetobacter baumannii: prevalence, antibiotic resistance profile and carbapenemase genes in clinical and hospital environmental strains.鲍曼不动杆菌对碳青霉烯类抗生素的耐药性:临床和医院环境菌株中的流行情况、抗生素耐药谱及碳青霉烯酶基因
BMC Infect Dis. 2025 Jun 2;25(1):786. doi: 10.1186/s12879-025-11169-x.
7
The intricacies of : a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications.……的复杂性:对一种多重耐药病原体及其临床意义和影响的多方面综合综述。 (注:原文开头部分不完整,翻译出来的句子也有部分成分缺失,不太能构成完整通顺的表述)
Front Microbiol. 2025 May 12;16:1565965. doi: 10.3389/fmicb.2025.1565965. eCollection 2025.
8
Antimicrobial Resistance in Sub-Saharan Africa: A Comprehensive Landscape Review.撒哈拉以南非洲地区的抗菌药物耐药性:全面概述
Am J Trop Med Hyg. 2025 May 20. doi: 10.4269/ajtmh.25-0035.
9
Identification of a Potential High-Risk Clone and Novel Sequence Type of Carbapenem-Resistant in Metro Manila, Philippines.菲律宾马尼拉大都会地区耐碳青霉烯类细菌潜在高风险克隆及新序列类型的鉴定
Antibiotics (Basel). 2025 Apr 1;14(4):362. doi: 10.3390/antibiotics14040362.
10
Antimicrobial resistance pattern of Acinetobacter baumannii clinical isolate in Ethiopia. A systematic review and meta-analysis.埃塞俄比亚鲍曼不动杆菌临床分离株的抗菌药物耐药模式。一项系统评价和荟萃分析。
BMC Infect Dis. 2025 Apr 12;25(1):518. doi: 10.1186/s12879-025-10923-5.
2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
4
Incidence and Molecular Characterization of Carbapenemase Genes in Association with Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from Tertiary Healthcare Facilities in Southwest Nigeria.尼日利亚西南部三级医疗机构耐多药铜绿假单胞菌临床分离株中产碳青霉烯酶基因的发生率及分子特征。
Curr Microbiol. 2021 Dec 14;79(1):27. doi: 10.1007/s00284-021-02706-3.
5
JMM Profile: Carbapenems: a broad-spectrum antibiotic.JMM 档案:碳青霉烯类:一种广谱抗生素。
J Med Microbiol. 2021 Dec;70(12). doi: 10.1099/jmm.0.001462.
6
Phenotypic characterization of carbapenem non-susceptible gram-negative bacilli isolated from clinical specimens.从临床标本中分离的耐碳青霉烯类革兰氏阴性杆菌的表型特征。
PLoS One. 2021 Dec 2;16(12):e0256556. doi: 10.1371/journal.pone.0256556. eCollection 2021.
7
Retrospective Data Insight into the Global Distribution of Carbapenemase-Producing .关于产碳青霉烯酶菌全球分布的回顾性数据洞察
Antibiotics (Basel). 2021 May 9;10(5):548. doi: 10.3390/antibiotics10050548.
8
Rapid Broad Spectrum Detection of Carbapenemases with a Dual Fluorogenic-Colorimetric Probe.使用双荧光-比色探针快速广谱检测碳青霉烯酶
J Am Chem Soc. 2021 May 12;143(18):6886-6894. doi: 10.1021/jacs.1c00462. Epub 2021 Apr 28.
9
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.《PRISMA 2020声明:报告系统评价的更新指南》
Syst Rev. 2021 Mar 29;10(1):89. doi: 10.1186/s13643-021-01626-4.
10
Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.肯尼亚目标革兰氏阴性菌碳青霉烯类不敏感临床分离株中多种碳青霉烯类和多重耐药基因及高危菌株类型的检测
PLoS One. 2021 Feb 22;16(2):e0246937. doi: 10.1371/journal.pone.0246937. eCollection 2021.